back to Australia directory
australia clinical guidance

Heavy menstrual bleeding (HMB) — assessment + first-line treatment

A detailed Australian summary of heavy menstrual bleeding (hmb) — assessment + first-line treatment, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Define heavy menstrual bleeding by its effect on physical, social and emotional quality of life, then document cycle pattern, intermenstrual and postcoital bleeding. Check pregnancy when possible, assess anaemia and bleeding disorder risk, and examine or image when symptoms suggest structural or malignant disease. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:HMB Clinical Care Standard

The Bottom Line

  • Define heavy menstrual bleeding by its effect on physical, social and emotional quality of life, then document cycle pattern, intermenstrual and postcoital bleeding.
  • Check pregnancy when possible, assess anaemia and bleeding disorder risk, and examine or image when symptoms suggest structural or malignant disease.
  • A full blood count is recommended for heavy bleeding; ferritin testing is targeted by anaemia and risk rather than universal panels.
  • Discuss medical options according to contraception and fertility goals, contraindications, likely reduction in bleeding and willingness to use hormonal treatment.
sources for this section:HMB Clinical Care Standard

Practical clinical workflow

1

Topic-specific assessment action

Define heavy menstrual bleeding by its effect on physical, social and emotional quality of life, then document cycle pattern, intermenstrual and postcoital bleeding.
2

Topic-specific diagnostic action

Discuss medical options according to contraception and fertility goals, contraindications, likely reduction in bleeding and willingness to use hormonal treatment.
3

Topic-specific management action

Refer for persistent symptoms, suspected fibroid or adenomyosis requiring procedural choice, failed medical therapy or concern for endometrial pathology.
4

Topic-specific follow-through

A levonorgestrel intrauterine system can provide contraception and bleeding control when the uterine cavity and preferences are suitable.
sources for this section:HMB Clinical Care Standard

Safety boundaries and escalation

  • Haemodynamic instability, syncope, severe anaemia symptoms, pregnancy-related bleeding or uncontrolled acute haemorrhage requires urgent hospital care.
  • Do not perform blind endometrial sampling in low-risk uncomplicated bleeding; select hysteroscopy or sampling through the Australian pathway.
sources for this section:HMB Clinical Care Standard

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO–RACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:HMB Clinical Care Standard

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:HMB Clinical Care Standard

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australian Commission on Safety and Quality in Health CareHeavy Menstrual Bleeding Clinical Care Standard2017 clinical care standard; current source page checked 2026-08-20 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.